IDEAYA Biosciences EPS IDYA

Diluted earnings per share by quarter and over the last twelve months, from 2018.

IDEAYA Biosciences' earnings per share was −$1.94 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$1.22.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$1.22	n/a	−$1.94
Q1 FY26	Mar 31, 2026	−$1.11	n/a	−$1.60
Q4 FY25	Dec 31, 2025	−$0.94	n/a	−$1.31
Q3 FY25	Sep 30, 2025	$1.33	n/a	−$1.86
Q2 FY25	Jun 30, 2025	−$0.88	n/a	−$3.79
Q1 FY25	Mar 31, 2025	−$0.82	n/a	−$3.59
Q4 FY24	Dec 31, 2024	−$1.49	n/a	−$3.30
Q3 FY24	Sep 30, 2024	−$0.60	n/a	−$2.33
Q2 FY24	Jun 30, 2024	−$0.68	n/a	−$2.19
Q1 FY24	Mar 31, 2024	−$0.53	n/a	−$2.01
Q4 FY23	Dec 31, 2023	−$0.52	n/a	−$1.97
Q3 FY23	Sep 30, 2023	−$0.46	−1250%	−$1.95

Companies in Drug Manufacturers - General nearest IDEAYA Biosciences' size, closest first, today.

Company	EPS, 12 months	Growth
IDYAIDEAYA Biosciences	−$1.94
OGNOrganon	$0.77	−71% a year
LQDALiquidia	$1.39
ARQTArcutis Biotherapeutics	$0.22
NRIXNurix Therapeutics	$2.31
INDVIndivior Pharmaceuticals	$2.78	+227% a year
PBHPrestige Consumer Healthcare	$3.57	−16% a year
HRMYHarmony Biosciences	$3.09	−0% a year
KNSAKiniksa Pharmaceuticals International	$0.97	+2325% a year
LGNDLigand Pharmaceuticals	$9.40
AMRXAmneal Pharmaceuticals	$0.49	+4800% a year
Peer median	$1.85